Merck Boosts FY25 Outlook; Launches Multiyear Optimization Initiative - Update
29/7 12:58
(RTTNews) - While reporting financial results for the second quarter on Tuesday, biopharmaceutical company Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, raised its adjusted earnings and sales guidance for the full-year 2025....